ARTHRODESE: Metatarsophalangeal Arthrodesis of the Hallux

Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05691075
Collaborator
(none)
150
29

Study Details

Study Description

Brief Summary

The purpose of the study is to describe the rate of bone fusion (radiological consolidation) in the 2 groups (A and B) 4 months after the operation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Arthrodesis of the metatarsophalangeal joint

Detailed Description

The main objective of the study is to describe the rate of bone fusion obtained with the different types of osteosynthesis material: dorsal plate, large-diameter compression screw.

Patients will be divided into two groups:
  • patient undergoing arthrodesis of the hallux with a large diameter screw (group A)

  • patient undergoing arthrodesis of the hallux by plate (group B)

This is a prospective, cross-sectional, open, comparative, non-randomized, non-interventional, monocentric study on two methods of synthesis (large-diameter plate or screw) of hallux metatarsophalangeal arthrodesis. Patients will be managed in accordance with current practice, the choice of surgical strategy (percutaneous / open) being left to the discretion of the investigators.

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Metatarsophalangeal Arthrodesis of the Hallux : Observational Study Evaluating the Efficacy and Tolerance of Synthetic Methods Using Dorsal Plate and Large-diameter Screws
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Jun 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Metatarsophalangeal arthrodesis of the hallux with large diameter screws

Patient who can benefit from first-line arthrodesis using large-diameter screws

Procedure: Arthrodesis of the metatarsophalangeal joint
Isolated surgery of the first ray of hallux valgus, hallux varus or hallux rigidus by percutaneous or conventional approach

Metatarsophalangeal arthrodesis of the hallux by plate

Patient who can benefit from a first intention arthrodesis by dorsal plate

Procedure: Arthrodesis of the metatarsophalangeal joint
Isolated surgery of the first ray of hallux valgus, hallux varus or hallux rigidus by percutaneous or conventional approach

Outcome Measures

Primary Outcome Measures

  1. Rate of bone fusion [4 months]

    Rate of bone fusion (radiological consolidation) in the 2 groups (A and B) 4 months after the operation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient undergoing isolated first ray surgery (M1 only) of hallux valgus, hallux varus or hallux rigidus by percutaneous or conventional approach;

  • Patient who can benefit from first-line arthrodesis using a dorsal plate or large-diameter screw;

  • Patient able to understand information related to the study and complete quality of life questionnaires;

  • Patient accepting study follow-up visits;

  • Patient having been informed and agreeing to participate in the study.

Exclusion Criteria:
  • Pregnant or breastfeeding women;

  • Patient undergoing lateral ray surgery;

  • Patient undergoing revision arthrodesis;

  • Patient with a loss of bone substance requiring a graft;

  • Patient suffering from chronic inflammatory disease;

  • Patient treated with long-term immunosuppressive or corticosteroid treatments;

  • Patient under guardianship or curatorship, or under a regime of deprivation of liberty.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • GCS Ramsay Santé pour l'Enseignement et la Recherche

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
GCS Ramsay Santé pour l'Enseignement et la Recherche
ClinicalTrials.gov Identifier:
NCT05691075
Other Study ID Numbers:
  • 2022-A02518-35
First Posted:
Jan 19, 2023
Last Update Posted:
Jan 19, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 19, 2023